The flumazenil market was estimated at around USD 18.5 million in 2021, growing at a CAGR of nearly 2.8% during 2022-2030. The market is projected to reach approximately USD 23.7 million by 2030. Flumazenil is a benzodiazepine inhibitor used to reverse the effects of postoperative drowsiness brought on by benzodiazepine anesthetics.
566 Digital
Jeetbuzz
Nhà Cái 789bet
Evergreen Urgent Care
33win World
Techgropse Ai Develoment Saudi Arabia
Mit Aoe
Graph Datum
Hdp Bioplast
Blogtruyenmoi